Vice President, Medical Affairs

About the role

The Vice President, Medical Affairs will play a pivotal role in shaping how Recursion translates breakthrough science, clinical data, real-world evidence, and AI-enabled insights into meaningful impact for patients, clinicians, investigators, and health systems. Reporting to the Chief Medical Officer, this high-impact, cross-functional leadership role focuses on building and leading the Medical Affairs strategy across Recursion's advancing clinical portfolio, particularly in oncology, rare disease, immunology, and other priority therapeutic areas.

Responsibilities

• Develop and lead integrated Medical Affairs strategies for priority assets, including scientific narrative, evidence gaps, stakeholder engagement, publication strategy, medical education, advisory boards, field medical planning, and launch readiness.
• Provide Medical Affairs support on cross-functional asset teams, partnering with Clinical Development, Regulatory Affairs, Development Sciences, HEOR/RWE, Biostatistics, Clinical Operations, Portfolio Strategy, Patient Advocacy, Communications, Legal/Compliance, and Business Development, where appropriate.
• Build evidence-generation plans that support asset differentiation, patient benefit, clinical adoption, and value demonstration, including real-world evidence, HEOR, epidemiology, natural history, burden of disease, treatment patterns, and outcomes-focused studies.
• Translate external insights from healthcare professionals, investigators, patient communities, payers, health systems, and scientific leaders into actionable recommendations for development strategy, trial design, endpoints, education needs, and evidence priorities.
• Lead scientific engagement strategy with key opinion leaders, digital opinion leaders, investigators, cooperative groups, patient advocacy organizations, professional societies, and other external stakeholders through compliant, high-quality scientific exchange.
• Partner with Recursion’s data science, platform, and Decision Science teams to explore responsible use of AI-enabled approaches for medical insights, evidence synthesis, stakeholder mapping, scientific communication, and measurement of medical impact.
• Establish the medical communication strategy for assigned assets, including publications, congress abstracts and presentations, lexicon, scientific platform, FAQs, medical information content, and internal scientific training.
• Design and build a structured, scalable Medical Affairs organization, including fit-for-purpose capabilities across medical strategy, field medical, medical communications, medical information, evidence generation, congress planning, insights, and medical excellence.
• Establish governance, operating rhythms, vendor partnerships, performance metrics, and compliant processes that enable Medical Affairs to support Recursion’s growth from clinical-stage development through potential launch readiness.

Requirements

Advanced clinical or scientific degree required; MD, DO, PharmD, PhD, or equivalent advanced degree strongly preferred. 15+ years of biotech or pharmaceutical industry experience, including significant leadership experience in Medical Affairs. Experience building and leading Medical Affairs strategy for clinical-stage or launch-stage assets, ideally in oncology, rare disease, immunology, or other specialty therapeutic areas. Proven ability to lead integrated evidence planning, including RWE, HEOR, epidemiology, burden-of-disease, natural history, treatment-pattern, outcomes, and value-focused studies. Strong understanding of drug development from early clinical development through launch readiness and lifecycle planning, including how Medical Affairs contributes to trial design, endpoint strategy, external engagement, publications, and evidence generation. Demonstrated success in engaging KOLs, investigators, patient advocacy organizations, professional societies, payers/HTA stakeholders, and other external experts through compliant scientific exchange. Experience developing scientific platforms, publication plans, congress strategies, advisory boards, medical education initiatives, and medical information resources. Strong working knowledge of relevant compliance expectations, including scientific exchange, medical review, publication practices, advisory board governance, and interactions with healthcare professionals across the US & globally.